Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection

Alcohol

Volumn 43, Issue 2, 2009, Pages 119-126

  Williams, Keith L ^a   Broadbridge, Carissa L ^b  

^a OAKLAND UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ethanol; Intraperitoneal; Naloxone; Naltrexone; Subcutaneous

Indexed keywords

NALTREXONE; SODIUM CHLORIDE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SELF ADMINISTRATION; EXPERIMENTAL RAT; MALE; NONHUMAN; RAT;

ALCOHOL DRINKING; ANIMALS; CONDITIONING, OPERANT; ETHANOL; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID; SELF ADMINISTRATION;

RATTUS;

EID: 60749098513     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2008.11.003     Document Type: Article

References (46)

1. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295 (2006) 2003-2017
2. Bienkowski P., Kostowski W., and Koros E. Ethanol-reinforced behaviour in the rat: effects of naltrexone. Eur. J. Pharmacol. 374 (1999) 321-327
3. Brick J. Standardization of alcohol calculations in research. Alcohol Clin. Exp. Res. 30 (2006) 1276-1287
4. Childers S.R., Creese I., Snowman A.M., and Snyder S.H. Opiate receptor binding affected differentially by opiates and opioid peptides. Eur. J. Pharmacol. 55 (1979) 11-18
5. Cichelli M.J., and Lewis M.J. Naloxone nonselective suppression of drinking of ethanol, sucrose, saccharin, and water by rats. Pharmacol. Biochem. Behav. 72 (2002) 699-706
6. Crabtree B.L. Review of naltrexone, a long-acting opiate antagonist. Clin. Pharm. 3 (1984) 273-280
7. Drobes D.J., Anton R.F., Thomas S.E., and Voronin K. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcohol Clin. Exp. Res. 28 (2004) 1362-1370
8. Emmerson P.J., Liu M.-R., Woods J.H., and Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta, and κ receptors in monkey brain membranes. J. Pharmacol. Exp. Ther. 271 (1994) 1630-1637
9. Froehlich J.C., Zweifel M., Harts J., Lumeng L., and Li T.-K. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 103 (1991) 467-472
10. Gardell L.R., Whalen C.A., Chattophadyay S., Cavallaro C.A., Hubbell C.L., and Reid L.A. Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcohol Clin. Exp. Res. 21 (1997) 1435-1439
11. Gianoulakis C. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J. Psychiatry Neurosci. 26 (2001) 304-318
12. Giruado S.Q., Grace M.K., Welch C.C., Billington C.J., and Levine A.S. Naloxone's anorectic effect is dependent upon the relative palatability of food. Pharmacol. Biochem. Behav. 46 (1993) 917-921
13. Heyman G.M. Preference for saccharin-sweetened alcohol relative to isocaloric sucrose. Psychopharmacology (Berl) 129 (1997) 72-78
14. Heyman G.M., Gendel K., and Goodman J. Inelastic demand for alcohol in rats. Psychopharmacology (Berl) 144 (1999) 213-219
15. Hill K.G., and Kiefer S.W. Naltrexone treatment increases the aversiveness of alcohol for outbred rats. Alcohol Clin. Exp. Res. 21 (1997) 637-641
16. Holter S.M., and Spanagel R. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology (Berl) 145 (1999) 360-369
17. Hyytia P., and Kiianmaa K. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcohol Clin. Exp. Res. 25 (2001) 25-33
18. Hyytia P., and Sinclair J.D. Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol Clin. Exp. Res. 17 (1993) 631-636
19. Ji D., Gilpin N.W., Richardson H.N., Rivier C.L., and Koob G.F. Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav. Pharmacol. 19 (2008) 1-12
20. June H.L., Grey C., Warren-Reese C., Durr L.F., Ricks-Cord A., Johnson A., et al. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats. Alcohol Clin. Exp. Res. 22 (1998) 2174-2185
21. Krishnan-Sarin S., Portoghese P.S., Li T.-K., and Froehlich J.C. The delta2 opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol. Biochem. Behav. 52 (1995) 153-159
22. Krishnan-Sarin S., Jing S.-L., Kurtz M., Zweifel M., Portoghese P.S., Li T.-K., et al. The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology (Berl) 120 (1995) 177-185
23. Krishnan-Sarin S., Wand G.S., Li X.W., Portoghese P.S., and Froehlich J.C. Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol. Biochem. Behav. 59 (1998) 627-635
24. Levine A.S., Weldon D.T., Grace M., Cleary J.P., and Billington C.J. Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. Am. J. Physiol. 268 (1995) R248-R252
25. Lukas G., Brindle S.D., and Greengard P. The route of absorption of intraperitoneally administered compounds. J. Pharmacol. Exp. Ther. 178 (1971) 562-564
26. Martin T.J., Walker L.E., Sizemore G.M., Smith J.E., and Dworkin S.I. Within-session determination of dose-response curves for heroin self-administration in rats: comparison with between-session determination and effects of naltrexone. Drug Alcohol Depend. 41 (1996) 93-100
27. Maldonado A.M., Finkbeiner L.M., Alipour K.K., and Kirstein C.L. Voluntary ethanol consumption differs in adolescent and adult male rats using a modified sucrose-fading paradigm. Alcohol clin. Exp. Res. 32 (2008) 1574-1582
28. Mason B.J., Salvato F.R., Williams L.D., Ritvo E.C., and Cutler R.B. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch. Gen. Psychiatry 56 (1999) 719-724
29. Mhatre M., and Holloway F. Mu1-opioid antagonist naloxonazine alters ethanol discrimination and consumption. Alcohol 29 (2003) 109-116
30. Modesto-Lowe V., and Fritz E.M. The opioidergic-alcohol link: implications for treatment. CNS Drugs 19 (2005) 693-707
31. Mucha R.F., and Iverson S.D. Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. Psychopharmacology (Berl) 82 (1984) 241-247
32. National Research Council. Guidelines for the Care and use of Mammals in Neuroscience and Behavioral Research (2003), National Academy Press, Washington DC
33. O'Malley S.S., Jaffe A.J., Chang G., Shottenfeld R., Meyer R.E., and Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 881-887
34. Paterson S.J., Corbett A.D., Gillan M.G.C., Kosterlitz H.W., McKnight A.T., and Robson L.E. Radioligands for probing opioid receptors. J. Recept. Res. 4 (1984) 143-154
35. 2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats. Alcohol Clin. Exp. Res. 27 (2003) 1554-1562
36. Pettinati H.M., O'Brien C.P., Rabinowitz A.R., Wortman S.P., Oslin D.W., Kampman K.M., et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J. Clin. Psychopharmacol. 26 (2006) 610-625
37. Rudski J.M., Billington C.J., and Levine A.S. Naloxone's effects on operant responding depend upon level of deprivation. Pharmacol. Biochem. Behav. 49 (1994) 377-383
38. Schwarz-Stevens K.S., Files F.J., and Samson H.H. Effects of morphine and naloxone on ethanol- and sucrose-reinforced responding in non-deprived rats. Alcohol Clin. Exp. Res. 16 (1992) 822-832
39. Sharpe A.L., and Samson H.H. Effect of naloxone on appetitive and consummatory phases of ethanol self-administration. Alcohol Clin. Exp. Res. 25 (2001) 1006-1011
40. Stromberg M.F., Casale M., Volpicelli L., Volpicelli J.R., and O'Brien C.P. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and b-funaltrexamine on ethanol consumption in the rat. Alcohol 15 (1998) 281-289
41. Stromberg M.F., Rukstalis M.R., Mackler S.A., Volpicelli J.R., and O'Brien C.P. A comparison of the effects of 6-beta naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats. Pharmacol. Biochem. Behav. 72 (2002) 483-490
42. Takemori A.E., and Portoghese P.S. Comparative antagonism by naltrexone and naloxone of mu, κ, and delta agonists. Eur. J. Pharmacol. 104 (1984) 101-104
43. Volpicelli J.R., Alterman A.I., Hayashida M., and O'Brien C.P. Naltrexone in treatment of alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 876-880
44. Walker B.M., and Koob G.F. Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence. Neuropsychopharmacology 33 (2008) 643-652
45. White D.A., and Holtzman S.G. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats. J. Pharmacol. Exp. Ther. 298 (2001) 156-164
46. Williams K.L. Development of naltrexone supersensitivity during food-maintained responding enhances naltrexone's ability to reduce ethanol-maintained responding. Alcohol Clin. Exp. Res. 31 (2007) 39-47